221
Participants
Start Date
June 8, 2022
Primary Completion Date
June 25, 2023
Study Completion Date
June 25, 2023
COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
The COVID-19 vaccine (Vero cell), Inactivated, Omicron Strain was developed by Sinovac Life Science Ltd.The product is a pre-filled syringe or a vial with an extractable volume of 0.5 mL. The antigen content is 1200 SOU/0.5 mL (6 µg/0.5 mL).
Gleneagles Hospital HongKong, Hong Kong
Sinovac Biotech (Hong Kong) Limited
INDUSTRY